Low Risk - Headache. Florbetapir f18 (trade name amyvid) is a new pet imaging agent that helps to diagnose alzheimer's disease. From the clinical trials, side effects (also called adverse reactions) were quite unusual, with no serious ones. The most common side effect was headache, occurring in 1.8% of the patients. Next was musculoskeletal pain (0.8%), followed by nausea and fatigue (each at 0.6%).
No. Only side effeect is a needle at the injection site.